Spermatogonial stem cells can convert into embryonic stem (ES) cell-like multipotent germline stem (mGS) cells in vitro and produce germline chimeras by blastocyst microinjection. Although homologous recombination was previously demonstrated in mGS cells, spermatogenesis was not found in chimeras, suggesting that they are not competent for germline modification. Here we conducted detailed analysis of chimeric animals to determine whether mGS cells retain germline potential after genetic manipulation. Spermatozoa that were deficient in the occludin gene could be recovered from animals that were chimeric with mGS cells that underwent homologous recombination. The phenotypes of the occludin knockout (KO) mice were similar to those reported for KO mice produced using ES cells, and the animals showed growth retardation, gastritis and male infertility. Furthermore, we found that heterozygous mGS cells acquire two copies of the G418-resistant genes and become homozygous for the targeted allele by culturing at high concentrations of G418. Cytogenetic analysis showed that the aneuploid mGS cells observed during genetic manipulation were trisomic for chromosome 8 or 11, which is a common chromosomal abnormality in ES cells. Thus, mGS cells can be used to produce KO animals, and this novel method of germline manipulation may prove useful in diverse mammalian species.
Introduction
Germline cells are unique in that they transmit genetic information from parent to offspring (de Rooij and Russell, 2000; Meistrich and van Beek, 1993) . In the postnatal period, only male germ cells initiate mitosis to become spermatogonial stem cells. These cells self-renew and also produce progenitor cells that eventually mature into spermatozoa. Female germline cells stop dividing after birth in most species, whereas spermatogonial stem cells continue to proliferate and support spermatogenesis throughout life in males.
Although germ cells are normally committed to producing mature gametes, several studies have shown that these cells are able to change their fate and convert into pluripotent cell types under certain conditions. Primordial germ cells (PGCs) originate from the epiblast 7.5 days postcoitum (dpc) in mice (McLaren, 2003) . These cells actively proliferate and migrate to the genital ridge in the middle of the gestation. By 11.5 dpc, most germ cells are located at the genital ridge, and female germ cells enter meiosis by 13.5 dpc. In contrast, by then male germ cells become proliferating gonocytes in the seminiferous cords, and the gonocytes stop proliferating at about 16 dpc. Between 8.5 and 12.5 dpc, mouse embryo PGCs can convert into Available online at www.sciencedirect.com Developmental Biology 312 (2007) 344 -352 www.elsevier.com/developmentalbiology pluripotent stem cells, known as embryonic germ (EG) cells, when they are cultured in the presence of stem cell factor (SCF), leukemia inhibitory factor (LIF) and basic fibroblast growth factor (bFGF) (Matsui et al., 1992; Resnick et al., 1992) . The phenotype and differentiation capacity of these cells are similar to those of ES cells derived from the inner cell mass (Evans and Kaufman, 1981; Martin, 1981) . EG cells form embryoid bodies and produce differentiated somatic cell types. They also contribute to embryonic development and produce germline chimeras when microinjected into blastocysts (Labosky et al., 1994; Stewart et al., 1994) . These studies demonstrated for the first time that germline cells can de-differentiate and acquire pluripotency. EG cells have also been derived from non-murine species, including humans (Shim et al., 1997; Shamblott et al., 1998; Park and Han, 2000) ; however, since EG cells could not be derived from germline cells at later developmental stages, it has been suggested that pluripotency is lost during the late fetal stage.
The characteristics of EG cells suggest that they may be used as vehicles for germline transgenesis in a manner similar to ES cells. However, there are no reports of the production of knockout (KO) mice using EG cells. The reason for this failure is unclear, but it may be related to genomic imprinting since the only difference between ES and EG cells is the genomic imprinting pattern; the level of site-specific methylation for certain imprinted genes is reduced in EG cells derived from embryos 11.5 and 12.5 dpc (Labosky et al., 1994; Tada et al., 1998) . Since genomic imprinting plays an important role in regulating the differentiation capacity of the cell, pluripotent cells derived from committed germ cells may be less stable than ES cells in terms of their germline potential.
We previously showed that spermatogonial stem cells from postnatal testes could be expanded over the long-term in vitro under culture conditions that included glial cell line-derived neurotrophic factor (GDNF), LIF, bFGF and epidermal growth factor (Kanatsu- Shinohara et al., 2003) . These cultured cells, called germline stem (GS) cells, continued to proliferate for at least 2 years in vitro, and they maintained their capacity to produce normal sperm and fertile offspring after transplantation into testes (Kanatsu-Shinohara et al., 2005a) . GS cells exhibit the characteristics of spermatogonial stem cells, and they are not pluripotent. Surprisingly, however, we recently found that ES cell-like pluripotent stem cells appeared in a GS cell culture during the establishment phase from neonatal testes (Kanatsu-Shinohara et al., 2004a) . Similar to ES/EG cells, these ES-like cells, which we designated as multipotent germline stem (mGS) cells, not only formed teratomas in vivo, but also differentiated into a variety of somatic cell types in vitro. The cells also produced germline chimeras by microinjection into blastocysts, demonstrating that pluripotency persists in these postnatal germ cells. Although several lines of evidence suggest that both cell types originated from spermatogonial stem cells, mGS cells cannot undergo spermatogenesis in the testis, while GS cells produce sperm in the testis but do not contribute to embryonic development (Kanatsu- Shinohara and Shinohara, 2006) .
Since GS and mGS cells can both be manipulated in vitro and produce offspring, the recent development of stem cell culture techniques for these cell types opens up new possibilities for germline transgenesis. Recently, we succeeded in producing KO mice by gene trapping and gene targeting using GS cells, but we were unable to produce KO mice using mGS cells (Kanatsu-Shinohara et al., 2006a) . The mGS cells that underwent homologous recombination failed to contribute to the germline following blastocyst injection. The failure to produce KO animals with EG and mGS cells suggests that pluripotent stem cells derived from germ cells have lower germline stability and limited potential for genetic modification.
Here we report the successful production of KO mice using mGS cells. The phenotypes of the mice were similar to those made by gene targeting in ES and GS cells.
Materials and methods

Cell culture
GS cells were cultured according to a previously established protocol (Kanatsu-Shinohara et al., 2003) , whereas mGS cells were cultured on mouse embryonic fibroblasts (MEFs) in standard ES cell culture medium, which consisted of Dulbecco's modified Eagle's medium/15% fetal calf serum and 10 3 U/ml LIF (ESGRO, Invitrogen, Carlsbad, CA)(Kanatsu- Shinohara et al., 2004a) . For selection of the double KO cells, GS and mGS cells were cultured on MEFs with various concentrations of G418 (Wako, Osaka, Japan). The selected clones were transferred to a 96-well plate and expanded for DNA analysis. G418 resistance was assessed by plating 3 × 10 4 cells on G418-resistant MEFs in a 12-well culture plate, and the number of surviving colonies was counted after 2 weeks of selection with 20 mg/ml G418. Embryoid bodies were produced by culturing mGS cells on bacterial dishes in the absence of LIF, as described previously (Saitou et al., 1998) .
Transplantation
For teratoma formation, approximately 4 × 10 6 double KO mGS cells were injected subcutaneously into KSN nude mice (Japan SLC, Shizuoka, Japan). The teratomas were recovered at 4-6 weeks after transplantation and analyzed by histological section. The Institutional Animal Care and Use Committee of Kyoto University approved all animal experimentation protocols.
Southern blot analysis
Genomic DNA was isolated by phenol/chloroform extraction, followed by ethanol precipitation. DNA transfer and hybridization were performed as described previously using probes for both exon 2 (internal) and intron 4 (external) probes (Kanatsu- Shinohara et al., 2005b Shinohara et al., , 2006a . The clones were also examined by hybridization with a cDNA fragment of the neo gene (nucleotides 187 to 804).
Combined bisulfite restriction analysis (COBRA)
The methylation status of the imprinted genes was assessed by COBRA, as described previously (Kanatsu-Shinohara et al., 2005a) . The polymerase chain reaction (PCR) products were digested with restriction enzymes that recognize the CpG motif. The intensity of the digested DNA was quantified using Mac Bas version 2.5 software (Fuji Photo Film, Tokyo, Japan).
Histological analysis
For histological analysis, the samples were fixed in 10% neutral buffered formalin and processed for paraffin sectioning. All sections were stained with hematoxylin and eosin.
Reverse transcriptase-polymerase chain reaction (RT-PCR) and Western blot analysis
Total RNA was prepared using TRIzol Reagent (Invitrogen). For RT-PCR, first strand cDNA was synthesized using Superscript™ II (RNase H − reverse transcriptase, Invitrogen). PCR was performed using primers specific for the mouse occludin gene, as described previously (Saitou et al., 1998) .
For the Western blots, the samples were lysed by homogenization with icecold lysis buffer (50 mM Tris-HCl, pH 6.8, 2% SDS, 20% glycerol, 2% 2mercaptoethanol, 0.01% bromophenol blue) supplemented with a protease inhibitor cocktail (Sigma, St. Louis, MO). Whole-cell extracts were separated by 10% SDS-polyacrylamide gel electrophoresis, transferred to Hybond-P membranes (Amersham Biosciences, Buckinghamshire, UK), blocked with 5% skim milk in Tris-buffered saline containing 0.1% Triton X-100 and probed with rabbit polyclonal anti-mouse occludin antibody (a gift from Dr. S. Tsukita, Kyoto University). Peroxidase-conjugated anti-rabbit IgG antibody (Cell Signaling, Danvers, MA) was used as the secondary antibody, and the protein bands were detected using the enhanced chemiluminescence detection method (LumiGLO™; Cell Signaling).
Microinsemination
The seminiferous tubules of the chimeric animals were dissected under UV light. Enhanced green fluorescent protein (EGFP)-expressing seminiferous tubules were recovered, and the germ cells were collected mechanically using fine forceps. Microinsemination was performed as described previously using round spermatids (Kimura and Yanagimachi, 1995) . Embryos that reached the two-cell stage after 24 h of culture were transferred to the oviducts of day 1 pseudopregnant ICR female mice. Fetuses that were retrieved on day 19.5 were raised by ICR foster mothers.
Chromosome analysis
The wild-type, heterozygous KO and double KO mGS cells harvested from culture dishes were treated with 0.075 M KCl for 15 min and were fixed with methanol/acetic acid (3:1). The chromosome slides were prepared using the standard method. The slides were stained with quinacrine mustard and Hoechst 33258. At least 20 metaphase cells were karyotyped for each cell type. The chromosomal aberrations, trisomic for chromosome 8 and/or 11, were confirmed by fluorescence in situ hybridization (FISH) analysis using mouse chromosome 8-and 11-specific probes (TAKARA BIO, Otsu, Japan).
Results
Production of KO mice by in vitro microinsemination using testicular sperm recovered from mGS chimeric mice
In a previous study, we generated chimeric animals using an EGFP-expressing mGS cell clone (clone 118) that was targeted to the mouse occludin gene locus (Kanatsu-Shinohara et al., 2006a) (Figs. 1A-C). Of the 43 offspring (14 males and 29 females) that matured into adults, we sacrificed seven males and 15 females. Although we found EGFP-positive cells in the ovaries of two females, we were not able to determine whether the mGS cells in the ovaries that contributed to the germ cells, somatic cells, or both. Furthermore, none of the seven males had contributions in the germline, as shown by EGFP fluorescence (Kanatsu- Shinohara et al., 2006a) . We sacrificed the remaining seven males to examine whether germline transmission had occurred with the mGS cells and found that the seminiferous tubules of one of the animals showed EGFP fluorescence under UV light (Fig.  1D ). This animal also had donor mGS cell contributions in its heart, pancreas and other organs (data not shown).
To generate offspring from this chimeric male, we used in vitro microinsemination, a technique commonly used to produce offspring in infertile animals and humans (Palermo et al., 1992; Kimura and Yanagimachi, 1995) . EGFP-expressing seminiferous tubules were dissociated using fine forceps, and the round spermatids thus recovered were used for in vitro microinsemination (Figs. 1E and F) . Of the 220 embryos constructed, 67 developed to the two-cell stage, and these were transferred into pseudopregnant ICR mothers. Ten offspring were born, and nine developed into normal mature adults (four males and five females). PCR analysis revealed that two of the males and two of the females were heterozygous for the targeted allele ( Fig. 1G ). COBRA revealed normal imprinting patterns in the H19, Meg3 IG, Igf2r and Peg 10 regions in the offspring, indicating that erasure and acquisition of the normal imprint had occurred successfully during germline development in the chimeric male ( Fig. 1H ).
To examine whether gene targeting in spermatogonial stem cells influences the phenotypes of KO animals, we generated two types of KO mice using mGS cells. One of the heterozygous males was bred with heterozygous females derived from gene targeting in GS cells (Kanatsu- Shinohara et al., 2006a) , while the other heterozygous male was crossed with the heterozygous females produced from mGS cells. The intercrosses between the heterozygous mGS KO male and the GS KO females yielded offspring that segregated with the expected Mendelian distribution: 12 wild-type, 23 heterozygous and 9 homozygous mutant (mGS/GS KO) pups were obtained from 6 litters. Likewise, intercrosses between the mGS heterozygous offspring produced 14 wild-type, 29 heterozygous and 9 homozygous mutant (mGS/mGS KO) pups in 8 litters. The lack of occludin mRNA and protein was confirmed in both types of KO mice (Figs. 1I and J). These results indicate that mGS cells can be used to produce KO mice by homologous recombination and germline transmission in a manner similar to ES cells.
Phenotypes of the KO mice
Results from ES cell-based occludin gene-targeting experiments demonstrated that homozygous occludin KO mice had postnatal growth retardation but no gross macroscopic phenotype (Saitou et al., 1998; Saitou et al., 2000) . In agreement with these observations, both the mGS/mGS and mGS/GS KO mice were normal in appearance, but they both showed growth retardation. Growth retardation was observed in both the males and females; both mGS/mGS and mGS/GS KO mice were ∼70% of the normal weight at 8 weeks of age ( Fig. 2A) . Similarly, the homozygous KO mice produced by gene targeting in GS cells (GS/GS KO) were ∼ 70% of the normal weight at 8 weeks of age ( Fig. 2A ). Even at more mature stages, the average weight of both types of KO mice was less than that of the wild-type animals.
We then conducted histological analyses of several organs from the KO mice. Previously, we found that the striated ducts of the salivary glands of occludin KO (GS/GS KO) mice lacked characteristic cytoplasmic granules (Kanatsu-Shinohara et al., 2006a) (Figs. 2B and C). Additionally, in the gastric gland showed predominant hyperplasia and numerous lymphocytes had infiltrated the gastric epithelium, indicating chronic gastritis (Figs. 2D and E). Furthermore, the KO animals had osteoporosis and exhibited significantly thinner trabeculae than did the wild-type animals ( Figs. 2F and G) . The animals also showed other pathological features, such as calcification in the brain (Figs. 2H and I). Similar abnormalities were found in all KO mice groups (mGS/mGS, mGS/GS and GS/GS), which is consistent with the findings in ES cell-based KO mice (Saitou et al., 2000) .
As the KO animals aged, their abnormalities gradually worsened. All KO animals had regenerating gastric epithelia due to constant inflammation. The most striking change, however, was observed in the testes. Although normal spermatogenesis was observed in young animals, germ cells were progressively lost from the seminiferous tubules of older animals (Figs. 3A-F) . When the testes were examined 9 months after birth, the number of spermatogenic cells was decreased possibly due to decreased proliferation of the spermatogonial stem cells, and only a small number of postmeiotic germ cells were found in these animals (Fig. 3E ). The epididymides of these animals did not contain any spermatozoa (Fig. 3F) , which is consistent with previous observations in ES cell-based KO animals (Saitou et al., 2000) .
As expected from our histological findings, the male KO mice either produced significantly smaller numbers of offspring or were completely infertile. We analyzed the fertility of GS/GS and mGS/mGS KO males by mating with wild-type females. In the case of the GS/GS KO mice, while all three wild-type males produced a total of 57 litters during a 6-month period, two of the three KO males produced 3 litters. The number of litters gradually decreased and the KO males were infertile when they are older than 3 month of age (Fig. 3G) . Likewise, while four wild-type males produced a total of 19 litters, three of the four mGS/mGS KO males produced a total of 3 litters during a 2month period. As with GS/GS KO males, the mGS/mGS KO animals were able to produce offspring only when the animals were less than 3 month old. In contrast, all female KO mice were fertile, and germline transmission of the targeted allele was confirmed in all groups (Fig. 1K ). 
Production of double KO mGS cells
To examine whether GS and mGS cells can be used to produce double KOs, GS and mGS cell clones that contained a single targeted occludin gene were cultured with various concentrations of G418. Cell cultivation at a high concentration of G418 is a routine method for producing homozygous KO ES cells (Mortensen et al., 1992) . Although the mGS cells were able to survive and proliferate at 20 mg/ml G418, the GS cells were unable to survive when the concentration of G418 exceeded 16 mg/ml; therefore, the selection process was conducted at a lower G418 concentration for the GS cells.
For the selection of mGS cell double KOs, a total of 5.4 × 10 6 targeted mGS cells (clone 118) were plated with 20 mg/ml G418, and 326 colonies were picked by micromanipulation, of which 203 clones were successfully expanded. Of the 203 mGS cell clones that survived the treatment with 20 mg/ml G418, two lost their heterozygosity, as detected by Southern blot analysis using three different probes (Fig. 4A) . The frequency of double KO cell production was slightly lower than that previously reported for experiments with ES cells (1.0% vs. 4.2%) (Saitou et al., 1998) . In comparison, a total of 6.9 × 10 6 targeted GS cells (clone 101) were plated at 8 mg/ml G418, 192 colonies were picked, and 141 clones were obtained. However, none of the GS cell clones that survived the treatment with 8 mg/ml G418 showed evidence of a loss of heterozygosity.
The two mGS cell clones retained their undifferentiated morphology, and their growth rate was comparable to that of the original clone with a single targeted allele. In agreement with results from ES cells (Mortensen et al., 1992) , both mGS cell lines were able to tolerate a higher concentration of G418 than the original clone. While mGS cells with a single targeted allele produced 15 colonies at 20 mg/ml G418, those with two targeted alleles produced 39 colonies, suggesting that the latter expressed more neo mRNA and protein (Fig. 4D) .
To confirm the loss of occludin gene expression, we analyzed the embryoid bodies produced by double KO mGS cells cultured in suspension for 4 days. RT-PCR and Western blot analyses showed no detectable occludin mRNA or protein in the two mGS cell clones (Figs. 4B and C) . Nonetheless, both double KO cells retained the ability to differentiate normally into somatic cells, and when these mGS cell lines were transplanted subcutaneously, both clones were able to differentiate into typical teratomas within 4 weeks. The tumors contained tissues from three germ layers, such as neuron, heart muscle and tracheal epithelium (Fig. 4E) .
Finally, to examine whether the loss of heterozygosity in the double KO cells was associated with chromosomal aberrations, karyotype analysis was performed for two G418-resistant clones (clones 25 and 131), with Hoechst 33258 banding after passage 26. The analysis revealed that, although clone 131 maintained a euploid karyotype, only 20% of clone 25 had 40 chromosomes (Fig. 4F ). Further analysis of clone 25 revealed that 76% of the cells were trisomic for chromosome 11 (Fig. 4G ). In addition, we found chromosomal abnormalities in wild-type mGS cells following long-term culture, including trisomy 8 and 11. The double KO clone 131 did not undergo any detectable translocations, additions or deletions, including in chromosome 13 where the occludin gene is located.
Discussion
To date the genetic manipulation of germline cells has been limited to eggs or oocytes. KO animals are generally produced by homologous recombination in ES cells (Nagy et al., 2003) . Alternatively, homologous recombination can be induced in primary somatic cells, using the nucleus as a donor for nuclear transplantation (McCreath et al., 2000) . However, ES cells with germline potential are only available in mice, and the techniques used cannot be applied to animal species with fragile or low numbers of oocytes. Genetic modification of the male germline may solve these problems. Spermatogonial stem cells can serve as a vehicle for germline modification using retrovirus vectors (Nagano et al., 2001; Hamra et al., 2002; Kanatsu-Shinohara et al., 2004b) ; however, with the advent of GS cell culture techniques, it is now possible to introduce homologous recombination in spermatogonial stem cells to produce KO animals (Kanatsu-Shinohara et al., 2006a) . In this study, we demonstrated a novel approach for male germline modification using mGS cells. In contrast to GS cells, which contribute to the germline by germ cell transplantation into seminiferous tubules, mGS cells form germline chimeras by microinjection into blastocysts (Kanatsu-Shinohara et al., 2004a) . Nevertheless, the phenotype of the mGS cell-derived KO mice was similar to those produced by GS or ES cell-based methods. Our mGS cellbased method is technically similar to ES cell-based approach and represents the fourth method for producing KO animals.
KO mouse production using mGS cells demonstrates that pluripotent stem cells from postnatal germ cells can be genetically manipulated in a similar manner to ES cells from early embryos. This was achieved despite the fact that these two cell types have different patterns of genomic imprinting (Kanatsu-Shinohara et al., 2004a) . The mGS cells have partial androgenetic imprinting, whereas the imprint patterns in ES cells are similar to those found in somatic cells, although the imprint patterns can change in both cell types during culture (Dean et al., 1998; Kanatsu-Shinohara et al., 2004a) . The level of imprinting per se may not directly influence germ cell commitment in pluripotent cells (Narashimha et al., 1997) , but it has a significant impact on somatic cell differentiation, which limits the survival and reproductive performance of chimeric animals. In fact, chimeras made with EG cells derived from 8.5 dpc PGCs had normal phenotypes, but those made with EG cells derived from PGCs in the genital ridges exhibited skeletal abnormalities and some died soon after birth (Labosky et al., 1994; Tada et al., 1998; Durcova-Hills et al., 2001) . These results probably reflect the erasure of imprinting that occurs in PGCs before migration into the gonads, and they also raise the possibility that KO mice may not be produced with mGS cells because of partial androgenetic imprinting patterns. That we successfully produced KO mice using mGS cells indicates that the epigenetic differences between ES and mGS cells may not pose a significant barrier to germline modification.
Interestingly, we observed that mGS cells have the same chromosomal defects that are frequently found in ES cells. Several studies have shown that ES cells often become trisomic for chromosome 8 or 11 during culture, and ES cells with these abnormalities rarely achieve germline transmission (Liu et al., 1997; Longo et al., 1997) . Human ES cells often exhibit similar non-random chromosomal abnormalities (Draper et al., 2004) . Such aneuploid cells usually outgrow normal euploid cells, and the euploid nature of the karyotype correlates closely with the level of chimerism, and it is aneuploidy more than the loss of totipotency that is considered to be detrimental for germline transmission in ES cells (Liu et al., 1997; Longo et al., 1997) . The occurrence of trisomy 8 and 11 during the culture of mGS cells strongly suggests that the chromosomal abnormalities seen in ES cells are not specific to ES cells and represent a more common problem in pluripotent mouse stem cells. Fig. 3 . Impaired spermatogenesis and decreased fertility in homozygous KO males. (A, B) Histological sections of wild-type mouse testis and epididymis at 9 months of age. Normal spermatogenesis was observed. (C-F) Histological appearance of KO mouse testes and epididymides. At 10 weeks of age, normal but decreased level of spermatogenesis was observed in the KO mice (C). Some spermatozoa were contained in the epididymides of the young KO mice (D). In contrast, at 9 months of age, the KO mice exhibited typical hypospermatogenesis (E), and no spermatozoa were observed in epididymides (F). (G) Reduced fertility in homozygous GS/GS KO mice. Wild-type or KO males were caged with wild-type females for 6 months, and the number of litters was recorded. Homozygous KO males produced significantly fewer offspring (mean ± SEM, n = 3; * P b 0.05 by t-test). Scale bar = 50 mm (A-F).
The results of our double KO cell experiments also highlight the close similarities between ES and mGS cells. Homozygous cells have been produced from heterozygous cultured cells by a variety of means. In this study, we followed the scheme for the selection of double KO ES cells production, and we found that those mGS cells that survived exposure to a high concentration of G418 produced double KO cells. Although the mechanism of double KO cell production in ES cells has long been unknown, a recent report suggests that it occurs as a result of local uniparental disomy or gene conversion between the targeted and non-targeted loci (Lefebvre et al., 2001) , and the same mechanism probably applies to mGS cells. The feasibility of double KO cell production from mGS cells may have important implications in clinical application because these cells may be used to produce differentiated somatic cells for regenerative medicine. In particular, because mGS cells can be derived from postnatal testes, this method may resolve the ethical problems surrounding ES cell-based regenerative medicine.
On the other hand, GS cells were significantly more sensitive to G418 than mGS cells, and we were unable to produce any double KO GS cells using the same procedure. One possible reason for the failure is inefficient selection of the GS cells (Kanatsu-Shinohara et al., 2005b) , which may be improved by optimizing our growth conditions. However, given the fact that GS cells maintain normal karyotypes after long-term culture (Kanatsu-Shinohara et al., 2005a) , we speculate that the configuration and/or stability of the chromosomes are significantly different between pluripotent stem cells and tissuespecific stem cells, and that GS cells have greater chromosomal stability, thereby preventing the spontaneous loss of heterozygosity observed in pluripotent ES/mGS cells. Further characterization of GS cells will be required to examine this possibility.
Despite the close similarities between our approach and the ES cell-based method, improvements must be made to increase the usefulness of our technique. A major obstacle in the germline modification of mGS cells was chimera production. It is known that 129 ES cells contribute more to the somatic and germline tissues in the chimeras than the C57BL/6 component (Papaioannou and Behringer, 2005) . In this study, we microinjected DBA/2 mGS cells into C57BL/6 × DBA/2 blastocysts, and one of the seven animals analyzed was identified a germline chimera. The donor cell contribution to coat color was low in this animal; however, this was successfully overcome by microinsemination in our experiments. Finding more suitable host will likely improve germline transmission. Another potentially important parameter is the stability of the germline potential in vitro. Different levels of germline transmission are achieved using different ES cell lines (Nagy et al., 2003; Papaioannou and Behringer, 2005) . While euploidy is one factor that influences the germline stability, the culture conditions of the ES cells also influences the maintenance of germline potential; serum-free medium generally produces better outcomes (Goldsborough et al., 1998) . Additional studies will provide important information to improve this technology.
A clear advantage of the current technique for KO mouse production is the use of different genetic backgrounds. While ES cells are derived almost exclusively from preimplantation embryos in a 129 background, mGS cells as well as EG cells can be derived not only from cells at later stages of development, but they are also available in several backgrounds (Matsui et al., 1992; Resnick et al., 1992 ; Kanatsu-Shinohara et Fig. 4 . Derivation of double KO mGS cells. A heterozygous KO clone (clone 118) was used for double KO cell production. (A) Southern blot analysis of DNA from the clones that survived G418 treatment. Genomic DNA was digested with the indicated restriction enzymes and hybridized with three different probes. The bands expected from the endogenous gene and resulting from homologous recombination are indicated in Fig. 1A. (B, C) The lack of occludin mRNA (B) and protein (C) in the double KO embryoid bodies, as determined by RT-PCR and Western blotting, respectively. (D) Levels of G418 resistance in wild-type, heterozygous and homozygous mGS cells. Equal numbers of wild-type, heterozygous KO and double KO mGS cells were plated on G418-resistant MEFs and cultured with 20 mg/ml G418. The number of surviving colonies was determined after 14 days of culture (mean ± SEM, n = 16; P b 0.01 by t-test). al., 2004a). Although improvements in ES culture conditions have led to the derivation of ES cells in several other inbred backgrounds (Schoonjans et al., 2003) , only limited number of gene targeting studies have used these cells, suggesting that 129 has a more stable germline potential. The difference in germline stability may simply reflect genetic differences, but it is also possible that the mechanism or origin of pluripotent cell derivation may significantly impact the stability of its germline potential. Indeed, it is possible that mGS cells achieve higher germline transmission rates than ES cells because of their germ cell origin. Whatever the mechanism involved, the use of different genetic backgrounds is advantageous in mouse functional genomics because otherwise substantial backcrossing is necessary to obtain mutant animals with inbred genetic backgrounds that can be used to study gene functions (Seong et al., 2004 ).
An important question that must be addressed in the future is whether this technique can be extended to other animal species. ES-like cells from testes have been reported not only in mice but also in other species, including humans (Cyranoski, 2006; Jung et al., 2007) . However, considering the close similarity between ES and mGS cells and the fact that only mouse ES cells have germline potential, the technology described here may not be applicable to animals other than mice. Nevertheless, the results of a recent study suggest that spermatogonial stem cells have more flexible differentiation potential than ES cells. Pluripotent cells from adult spermatogonia (i. e. multipotent adult germline stem cells) achieved germline transmission following microinjection either into the seminiferous tubules or the blastocyst cavity (Guan et al., 2006) . This result was unexpected because previous attempts to demonstrate germline transmission by injection into seminiferous tubules failed with ES and mGS cells (Brinster and Avarbock, 1994; Kanatsu-Shinohara et al., 2004a) . Therefore, a spermatogonia-based approach may resolve critical problems with ES cell technology. More extensive studies are clearly required to determine whether mGS cells can also undergo germline transmission by germ cell transplantation and whether the pluripotent cells from spermatogonia are a better vehicle for germline modification than ES cells.
Genetic modification of spermatogonial stem cells provides a new opportunity for germline manipulation. Spermatogonial stem cells can be cultured in the absence of serum or feeder cells (Kanatsu-Shinohara et al., 2005c , 2006b , and they produce offspring following xenogeneic transplantation into smaller surrogate animals . The current study demonstrates the feasibility of KO mouse production using mGS cells. Hopefully, this technique will be useful for the germline modification in animal species, in which genetic manipulation is very difficult or impossible.
